id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
bam-10582	Moghimi, Minoosh; Jozpanahi, Manijeh; Khodadadi, Kasra; Saeed, Seyede Pegah; Pirsaraie, Seyede Vanoushe Azimi; Jalili, Nooshin	Red cell distribution width, a predictive factor in immunocompromised patients with COVID-19: A comparison retrospective study between cancer and kidney transplant patients	2022	9	.pdf	application/pdf	4681	273	58	Because of their underlying condition and treatment complication, they are often immunosuppressed.2 Many individuals assume that cancer patients who receive systemic anticancer drugs are at a higher risk of developing the disease than patients who do not receive anticancer treatment.3 There is few information on the risk of developing COVID-19 in hematological cancer patients. Eur J Transl Myol 32 (2): 10582, 2022 doi: 10.4081/ejtm.2022.10582 The pandemic of COVID-19 has a huge effect on public health and is still a major cause of death in Iran.1 During the COVID-19 pandemic, cancer patients are an especially vulnerable group.	cache/bam-10582.pdf	txt/bam-10582.txt